Rajesh Kumar Sethi, National Coordinator of the Minority Department of the All India Congress Committee (AICC) in Manipur, ...
New legislation will require schools to use Mandarin by default, taking priority over minority ethnic languages such as Tibetan, Uyghur and Mongolian ...
Over a decade after a disastrous debut plagued with faceless NPCs and frame rate issues, Assassin's Creed Unity is rounding ...
Trump ordered agencies to stop using Anthropic amid a dispute between the AI giant and the DoD. Shortly after Trump's announcement, the DoD moved to label Anthropic a supply-chain risk. Anthropic said ...
President Donald Trump ordered U.S. government agencies to "immediately cease" using technology from the artificial intelligence company Anthropic. The AI startup faces pressure by the Defense ...
US President Donald Trump has said he would direct every federal agency to immediately stop using technology from AI developer Anthropic. "We don't need it, we don't want it, and will not do business ...
Attention, gamers: if you thought new titles on top of the endless cavalcade of sequels and remakes were derivative now, wait till you hear about what the game engine maker Unity has got in store.
Making a video game usually means learning to code, working with complex game engines, and spending hours piecing everything together. That is true even for simple casual games. Many aspiring ...
Chelsea Hylton is a web producer for CBS Los Angeles. An Inglewood native, Hylton has her master's degree from USC. She covers local breaking news across the Southern California region. Before joining ...
Los Angeles Mayor Karen Bass signed a new executive directive Tuesday that bans federal immigration agents from using city-owned or city-controlled property and orders the LAPD to preserve all ...
That handy ‘Summarize with AI’ button embedded in a growing number of websites, browsers, and apps to give users a quick overview of their content could in some cases be hiding a dark secret: a new ...
GLEN ALLEN, Va., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results